Tag: Vepdegestrant

Posted on

UPSC Current Affairs Quiz – 8 July 2026 | Daily Prelims Quiz

We’re excited to introduce a beta version of our new Current Affairs Quiz interface. This is something we’ve been working on to make your quiz-taking experience smoother, more useful, and more exam-oriented. The new interface comes with improved review, better result analysis, category-wise performance,  retake option, and a cleaner overall experience. Since this is still …

Continue reading “UPSC Current Affairs Quiz – 8 July 2026 | Daily Prelims Quiz”

Posted on

UPSC CURRENT AFFAIRS – 7 JULY 2026

The current affairs articles focus on strengthening democracy, technology governance, security, and conservation. They argue that the right to vote should be recognized as a constitutional right linked to democratic principles. India is urged to lead Global South-centric AI governance emphasizing fairness, digital sovereignty, and equitable benefits. The NCW Women Helpline (14490) enhances women's safety …

Continue reading "UPSC CURRENT AFFAIRS – 7 JULY 2026"

Posted on

Vepdegestrant

Source: THSubject: Science and technology Context: The U.S. Food and Drug Administration (FDA) has approved vepdegestrant, marking a historic milestone as the world’s first-ever approved therapy based on PROTAC (Proteolysis-Targeting Chimera) technology. Vepdegestrant About Vepdegestrant: What It Is? Vepdegestrant is a first-in-class, orally administered therapeutic molecule designed using PROTAC technology. Instead of merely blocking a …

Continue reading "Vepdegestrant"